QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
Free Trial
OTCMKTS:TPIY

Tianyin Pharmaceutical (TPIY) Stock Price, News & Analysis

→ Nvidia Has a BIG Problem — Here’s Who Benefits MOST (From Weiss Ratings) (Ad)
Free TPIY Stock Alerts
$0.0001
+0.00 (+∞)
(As of 07/15/2019)
Compare
Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0178
Volume
88,900 shs
Average Volume
36,100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
TPIY stock logo

About Tianyin Pharmaceutical Stock (OTCMKTS:TPIY)

Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.

TPIY Stock Price History

TPIY Stock News Headlines

April 13, 2024 | americanbankingnews.com
Tianyin Pharmaceutical (OTCMKTS:TPIY) Shares Pass Above 200-Day Moving Average of $0.00
March 17, 2023 | wsj.com
Tasly Pharmaceutical Group Co. Ltd. A
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 2, 2023 | uk.investing.com
Tianjin Chase Sun Pharmaceutical Co Ltd (300026)
February 28, 2023 | wsj.com
Tianjin Chase Sun Pharmaceutical Co. Ltd.
February 25, 2023 | seekingalpha.com
Arrowhead Pharmaceuticals Requires Caution
February 23, 2023 | uk.finance.yahoo.com
A Look At The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
February 23, 2023 | wsj.com
Tianjin Tianyao Pharmaceutical Co. Ltd.
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 22, 2023 | morningstar.com
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class S
February 18, 2023 | marketwatch.com
Rifampicin Market Analysis by Application like Tuberculosis, Leprosy, Legionnaire's Disease, Others)
February 9, 2023 | marketwatch.com
Permethrin Spray Market to Grow Exponentially Due to Rising Demand
February 8, 2023 | marketwatch.com
Doxofylline Tablets Market is set to see Revolutionary growth in decade
February 8, 2023 | marketwatch.com
Dactinomycin Market is anticipated to boost sales at a Impressive CAGR
February 1, 2023 | marketwatch.com
Cyclopentanone (Cas 120-92-3) Market : Future Growth with Technology and Current Trends 2023 to 2029
January 23, 2023 | marketwatch.com
Mycophenolic Acid Market 2023 : Profiling Key Players, Value Estimation and Analysis by Recent Trends to 2028
January 20, 2023 | marketwatch.com
Dibucaine(Cinchocaine) API Market Size, Share, Growth, Revenue, Demand, Future Potential, and Forecast from 2023 to 2029
January 12, 2023 | msn.com
Six types of Benylin and Nurofen for children among medicines in short supply
See More Headlines
Receive TPIY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:TPIY
Previous Symbol
NYSEMKT:TPI
CUSIP
N/A
CIK
1362718
Web
www.tianyinpharma.com
Phone
00-86-028-8551-6696
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
54.39
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Guo Qing Jiang
    Chairman, President & Chief Executive Officer
  • Tao Yang
    Chief Operating Officer
  • Li Ying Wang
    Financial Controller
  • Ying Zhang
    Director-Human Resources

Key Competitors

View All Competitors

TPIY Stock Analysis - Frequently Asked Questions

How have TPIY shares performed in 2024?

Tianyin Pharmaceutical's stock was trading at $0.0001 at the beginning of the year. Since then, TPIY stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Tianyin Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tianyin Pharmaceutical investors own include International Business Machines (IBM).

How do I buy shares of Tianyin Pharmaceutical?

Shares of TPIY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TPIY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative